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The aim of this study was to evaluate the cytotoxic potential of a novel nickel(II) complex
(NTC) against WiDr and HT-29 human colon cancer cells by determining the IC50 using
the standard MTT assay. The NTC displayed a strong suppressive effect on colon cancer
cells with an IC50 value of 6.07 ± 0.22µM and 6.26 ± 0.13µM against WiDr and HT-29
respectively, after 24 h of treatment. Substantial reduction in themitochondrial membrane
potential and increase in the release of cytochrome c from the mitochondria directed
the induction of the intrinsic apoptosis pathway by the NTC. Activation of this pathway
was further evidenced by significant activation of caspase 3/7 and 9. The NTC was also
shown to activate the extrinsic pathway of apoptosis via activation of caspase-8 which
is linked to the suppression of NF-κB translocation to the nucleus. Cell cycle arrest in the
G1 phase was confirmed by flow cytometry and up-regulation of glutathione reductase
expression was quantified by qPCR. Results of the current work indicates that NTC
possess a potent cancer cell abolishing activity by simultaneous induction of intrinsic
and extrinsic pathways of apoptosis in colon cancer cell lines.
Keywords: apoptosis, cell cycle arrest, nickel(II) complex, NF-κB, colon cancer
INTRODUCTION
Colon cancer is the third common type of cancer and the second foremost cause of cancer death
when both sexes are pooled (Siegel et al., 2015). Following failure of normal replacement of lining
cells in the colon, cells begin to divide abnormally which results in formation of polyps. As polyps
grow, further genetic mutations destabilize the cells to invade other layers of the colon. Despite
significant diagnostic strategies in colon cancer and application of different modalities, including
surgery, chemotherapy, and radiotherapy, the relapse and metastasis are still considered incurable
and the 5-year relative survival rate is approximately 15% (Ferlay et al., 2014).
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Apoptosis has been predominantly considered as one of the
most important targets in anti-cancer therapy. This signaling
pathway has a fundamental role in the emergence of cancer
and the patient’s response to treatment (Lowe and Lin, 2000).
Apoptosis promotes the process of programmed cell death
through the extrinsic and/or mitochondrial (intrinsic) pathways,
regulated by a number of gene families. By contrast, activation of
the extrinsic pathway is through the cell surface death receptors,
whereas the intrinsic pathway can be independently induced by
an extensive array of signals such as cytotoxic drugs, cellular
stress, and radiation. Defect in these pathways can endorse
neoplastic development or resistance to anticancer therapies
(Kranz and Dobbelstein, 2012). Targeting the key proteins
involved in apoptosis signal transduction can improve cell death
and thus overcome the clinical consequence in cancer therapy.
They are including PI-3K/Akt (Huang et al., 2001), HIF-1α
(Viemann et al., 2007), NF-κB (Chen et al., 2001; Huang et al.,
2002; Cruz et al., 2004), AP-1 (Wisdom, 1999; Cruz et al., 2004),
and NFAT(Huang et al., 2001; Cai et al., 2011) by influencing
the expression pattern of transcription factors and inducing
epigenetic mechanisms such as DNAmethylation, loss of histone
acetylation rather than indirect DNA damage (Salnikow and
Zhitkovich, 2007; Arita and Costa, 2009).
The water-soluble nickel salts are less toxic than water-
insoluble compounds (Cempel and Nikel, 2006). The potency
of nickel compounds is related to the ability of Ni2+ to
access chromatin, where it produces an increased chromatin
condensation, enhanced DNAmethylation, and turning off of the
transcription of tumor suppressor and senescence genes (Zhou
et al., 1998). Following the entry into the cell, nickel compounds
stimulate generation of reactive oxygen species (ROS) which
cause multiple types of cellular and nuclear damage either
through direct or indirect mechanisms (Salnikow et al., 2000;
Waris and Ahsan, 2006). The aim of this study is to evaluate the
cytotoxic properties of a novel nickel(II) complex (NTC) against
human colon cancer cells through targeting apoptotic pathways.
MATERIALS AND METHODS
Reagents and Chemicals
All chemicals are commercially available and used as received.
The elemental analyses for C, H, and N were carried out on a
Thermo Finnigan Flash EA 1112 (Thermo Scientific, Hudson,
NH, USA). The infrared spectra were obtained on a Perkin-
Elmer Spectrum 400 spectrometer with samples as KBr pellets
in the region 4000–400 cm-1. The UV-vis spectra were obtained
using a Shimadzu UV-vis-NIR 1600 spectrophotometer. 1H-
NMR spectra were recorded on a JEOL FT-NMR lambda 400
MHz spectrometer. The solvent was DMSO-d6. The chemical
shifts were reported in ppm using the residual protonated solvent
as the reference.
General Procedure of Synthesis of the
Thiophene-Based Ligand (L)
2, 4-Diamino-6-phenyl-1, 3, 5-triazine (18.89 g; 100.9mmol) was
added portionwise to a solution of 2, 5-thiophenedicarboxylic
acid (12.93 g; 100.9mmol) in absolute ethanol (100mL). The
mixture was refluxed for 2 h and then left to cool to room
temperature. The white powder formed was filtered, washed with
ethanol and dried in an oven at 80◦C. The yield was as follows
31.15 g, 97.9%. 1H NMR (400 MHz, DMSO-d6): δ = 8.23–8.25
(d, 2H, ar-H3), 7.71 (s, 1H, NH), 7.44–7.51 (m, 2H, ar-H1, H-2),
6.80 (b, 2H, ar-H4). Anal.calc. for C15H11N5O3S: C, 52.8; H, 3.3;
N, 20.5. Found: C, 52.6; H, 3.9; N, 20.7. Formula weight, 341.34 g
mol−1. IR, cm−1: 3324 (N-H), 1672 (C=O amide).
Synthesis of Ni (II)-Complex with
Thiophene Based Ligand
Nickel(II) hexadecanoate (0.80 g; 1.4mmol) was added to an
ethanolic suspension of L (0.48 g; 1.4mmol), and the mixture
was heated under reflux for 3 h. The greenish powder formed
was filtered from the hot reaction mixture, washed with ethanol,
and dried in an oven at 100◦C. Yield: (0.84 g, 65.6%). Anal. calc.
for Ni2C79H133N5O10S: C, 64.9; H, 9.2; N, 4.8. Found: C, 64.6;
H, 9.4; N, 4.1. Formula weight, 1462.38 g mol−1. IR, cm−1: 3326
(N-H), 2916 (CH2asy), 2849 (CH2sym), 1617 (C=O amide), 1525
(COOasy), 1395 (COOsym), 569 (Ni-N).
Cell Lines and Cell Culture
The human colon cell line, CCD-18Co, and colon cancer cell
lines, WiDr and HT-29, were purchased from the American Type
Culture Collection (ATCC, Manassas, Virginia, USA). WiDr and
CCD-18Co cells lines were cultured in Eagle’sMinimumEssential
Medium and HT-29, in RPMI-1640 supplemented with 10% heat
inactivated fetal bovine serum (FBS, Sigma-Aldrich, St. Louis,
MO), 1% penicillin and streptomycin. All cell lines were cultured
in a humidified incubator with 5% CO2 at 37
◦C. All experiments
were conducted on cell lines with passage number 1–10.
Cell Proliferation Assay
The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide] assay was carried out to evaluate
the anti-proliferative activity of the nickel(II) complex (NTC).
Briefly, cells were seeded (100µl) 24 h prior to treatment in a
96-well plate at 7×104 cells/ml. NTC and 5-fluoruracil as control
positive were dissolved in 0.1% DMSO (Sigma Chemical Co., St.
Louis, Missouri, USA). After incubation of the plates for 24, 48,
and 72 h at 37◦C with 5% CO2, 50µl of MTT solution (2mg/ml;
Sigma) was added to each well and then plates were incubated
for 4 h at the same conditions. To dissolve the purple formazan
crystals formed at the bottom of the wells, 100µl DMSO was
added to each well and incubated for 20min. Absorbance was
subsequently read at 570 nm using a spectrophotometric plate
reader (Hidex, Turku, Finland). The dose-response curves were
plotted to obtain the IC50 values. Experimental data were derived
from three independent experiments. The selectivity index was
obtained by mean IC50 CCD-18Co/mean IC50 of WiDr or
HT-29.
Measurement of the Released LDH
Quantitative measurement of lactate dehydrogenase (LDH)
released into the media from damaged cells as a biomarker
for cellular cytotoxicity and cytolysis was carried out according
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to Wang et al. (2014) with slight amendment. Briefly, cells
were treated with different concentrations of NTC and Triton
X- 100 (positive control) for 48 h followed by transfer of the
supernatants of untreated and treated cells to a new 96-well
plate for LDH activity analysis. 100µL of LDH reaction solution
was then added to each well, followed by incubation at room
temperature for 30min. The absorbance was read at 490 nm
using a Tecan Infinite 200 Pro (Tecan, Mannedorf, Switzerland)
microplate reader. LDH activity of the cells was assessed by the
amount of formazan salt and intensity of red color in treated
and untreated samples. Release of LDH level in treated cells was
expressed as a percentage of LDL release in the positive control.
Immunofluorescence
After 24 h NTC treatment of both cancer and normal cells,
mitochondrial membrane potential (MMP) and cytochrome c
release were analyzed using JC-1 assay kit (Life Technologies,
Gaithersburg, MD, USA) and ApoTrack cytochrome c apoptosis
ICC antibody kit (Abcam Inc., Cambridge, MA, USA),
respectively, according to the manufacturer’s protocol. Cells were
then fixed in 4% paraformaldehyde, permeabilized by 0.25%
Triton X-100 and then were quenched with 50mM ammonium
chloride and blocked with 5% BSA in PBS overnight, followed
by probing with 10µg/mL DY350-Phalloidin and 4µg/mL
Hoechst 33,342 (Thermo Scientific, Hudson, NH, USA) and was
incubated at room temperature for 20min. Finally, cells were
washed with PBS and coverslips were mounted using polyvinyl
alcohol mounting medium (Fluka Analytical, Milan, Italy).
Fluorescence was analyzed using the Radiance 2100 confocal
microscope (Bio-Rad, Hercules, CA, USA). Noise reduction was
attained by Kalman filtering during application and data was
analyzed with Data Viewer version 3.0.
Annexin-V-FITC Assay
Cells were treated with cell membrane permeable calcium
chelator (EGTA/AM, 25mM, Life Technologies, Gaithersburg,
MD, USA) for a period of 1 h prior to addition of NTC (6.0µM).
After 24 h treatment, cells were harvested, washed twice with
PBS, resuspended in Annexin-V binding buffer (BD Biosciences,
San Jose, CA, USA) and stained with Annexin-V-FITC (BD)
and PI (Sigma) according to the manufacturer’s protocol. The
fluorescence intensity was then examined using FACSCanto II
(BD Biosciences, San Jose, CA). Onset of early and late apoptosis
were determined using Annexin-V, whereas PI was utilized for
distinguishing necrosis and late apoptosis.
Determination of Apoptotic Properties
Accurate determination of live/dead nucleated cell concentration
in the sample was accomplished by the minor modified version
of the method described by Rahman et al. (2014). Propidium
iodide (PI) and acridine orange (AO) double staining assay was
performed to detect the early and late apoptotic properties of
the treated cancer cells according to the standard procedure.
Cells were incubated with NTC (6.0µM) for 24, 48, 72 h and the
harvested cells were stained with acridine orange and propidium
iodine and observed within 30min with a UV-fluorescent
microscope (Bio-Rad, Hercules, CA, USA).
ORAC Antioxidant Assay
Organisms have complex antioxidant systems to protect
themselves from oxidative stress; however, excess oxidative stress
can overwhelm the systems and cause severe damage. Tomeasure
the antioxidant protection potential of NTC over time, the
ORAC assay was used. In a black 96-well plate, 6.0µM of NTC,
blank (solvent/PBS) and standard (5-fluouracil) were added
to cells supplemented with fluorescein solution (150µL) and
incubated at 37◦C for 5min. AAPH (25µL) was then added
and fluorescence intensity was assessed at 485 nm (excitation
wavelength) and 538 nm (emission wavelength) every 2min for
a duration of 2 h. Quantification was carried out by calculating
the differences of area under the fluorescence decay curve of the
samples and blank.
Detection of ROS Production
ROS is produced as byproducts during the mitochondrial
electron transport and has potential to cause apoptosis.
Production of intracellular ROS was detected by using 10mM
dihydroethidium (DHE) stock solution (in methanol) diluted
500-fold in HBSS without serum or other additives to yield
a 20mM working solution. The cells in the black plate were
washed twice with HBSS after exposure to NTC and then
incubated in 100µLworking solution of DHE at 37◦C for 30min.
Fluorescence of DCF in each cell was captured, extracted and
analyzed with Radiance 2100 confocal microscope (Bio-Rad,
Hercules, CA, USA).
Evaluation of NF-κB Translocation
Nuclear factor kappa-light-chain-enhancer of activated B
cells controls transcription of DNA and is involved in
cellular responses to stimuli such as stress, free radicals
and chemicals. Cells were treated with NTC (6.0µM) and
stimulated with TNF-α. The cells were then stained according
to the instructions of the Cellomics nuclear factor-kB (NF-
κB) activation kit (Thermo Scientific). The cytoplasmic
and nuclear NF-κB intensity ratio (average intensity of
200 cells/well) was measured using cytoplasm to nucleus
translocation bio-application software (S50-5001-1, Thermo
Scientific).
Gene Expression Analysis
WiDr and HT-29 cells were treated with NTC (6.0µM) for 24 h.
Total RNA was extracted using RNeasy plus mini kit (Qiagen).
Reverse transcription of 1mg RNA into cDNA was carried out
by using RT2 first strand kit (SA Biosciences, Qiagen). RT2
Real Time TM SYBR Green/fluorescein PCR master-mix was
then mixed with cDNA and loaded into each of 96 wells of
the 84 genes by qPCR array according to the manufacturer’s
protocol (SA Biosciences, Qiagen). Differential expression of the
members of antioxidant peroxiredoxin (PRDX) family and redox
control are involved in human oxidative stress and cellular stress
response were analyzed. Concisely, 12.5ml master mix, 11.5ml
double distilled water, and 1ml cDNA was mixed to reach the
final volume of 25ml PCR mixture and 25µl was loaded to each
individual well of the 96 well plate. QuantStudio™ 12K Flex Real-
Time PCR System (Life Technologies, Bleiswijk, Netherlands)
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consuming ssoFast EvaGreen Supermix (Bio-Rad) was operated
according to the manufacturer’s protocols. Primers were
synthesized as GR F5′-AACATCCCAACTGTGGTCTTCAGC-
3′, GR R5′-TTGGTAACTGCGTGATACATCGGG-3′, β-actin
F5′-GATGACCCAGATCATGTTTGAGACC-3′ and β-actin
R5′-AGTCCATCACGATGCCAGTGGT-3′. Amplification was
operated at 95◦C for 10min, followed by 40 cycles at 95◦C for 15 s
and 60◦C for 1min. The average expression of five housekeeping
genes including β-actin (ACTB), β-2-microglobulin (B2M),
hypoxanthine phosphoribosyltransferase 1 (HPRT1), ribosomal
protein L13a (RPL13A) and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was considered for normalization of
mRNA expression of each gene. Difference in gene expression
between piperazine and untreated control was calculated by the
RT Profiler qPCR-array data analysis software to measure the
fold changes.
FIGURE 1 | (A) The synthetic steps for the preparation of ligand. (B) The structural formula of L was ascertained from 1H-NMR and FTIR spectroscopies. The amide
protons appear as a singlet at 7.71 ppm, and all aromatic protons appear as a multiplet in the range 7.44–7.51 ppm. (C) Ni (II) complex containing polymeric ligand
was synthesized as a greenish precipitate in ethanolic solution owing to their low ethanol solubility. The complex is a dinuclear repeat unit and stable toward air and
moisture. It is soluble in DMSO but insoluble in common organic solvents.
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Evaluation of Mitochondrial and Extrinsic
Apoptotic Pathways
Caspases are a family of cysteine proteases that have critical roles
in apoptosis. Caspase 8 is involved in mitochondrial (intrinsic)
whereas, caspase 8 in the extrinsic pathway of apoptosis. Caspase
3 interacts with caspase-8 and caspase-9 and plays a central
role in the execution-phase of cell apoptosis. Time-dependent
evaluation of caspase-3/7, -8, and -9 activities in the presence
of NTC (6.0µM) were performed using assay kits Caspase-Glo
3/7, 8, and 9 (Promega Corp., Madison, WI, USA) in triplicates
on white 96-well after 6, 12, 18, 24, and 30 h. Treatment of
the cells with NTC (6.0µM) was carried out 24 h prior to the
TABLE 1 | MTT cell proliferation assay for 24, 48, and 72h on normal and
cancer cells.
Time (h) WiDr HT-29 CCD-18Co
IC50 (µM) of nickel(II) complex (NTC)
24 6.07 ± 0.22 6.26 ± 0.13 55.16 ± 0.07
48 5.87 ± 0.35 6.02 ± 0.02 53.25 ± 0.11
72 5.65 ± 0.11 5.91 ± 0.23 52.94 ± 0.06
IC50 (µM) of 5-fluoruracil (5-FU)
24 1.08 ± 0.14 1.17 ± 0.06 1.33 ± 0.15
experiment on a total of 10,000 cells per well. A 100ml of the
caspase-Glo reagent added and incubated at room temperature
for 30min. The substrate of luciferase enzyme will be released
from apoptotic cells due to caspase activation after cleavage of the
aminoluciferin-labeled synthetic tetrapeptide. Caspase activities
were measured using Tecan Infinite 200 Pro (Tecan, Mannedorf,
Switzerland) microplate reader.
Molecular Identification of Apoptotic
Proteins Induced by NTC
Apoptotic proteins have central role in regulation of
programmed cell death via inducing (pro-apoptotic) or
inhibiting (anti-apoptotic) apoptosis. 1 × 106 cells/mL were
treated with NTC and standard (5-fluorouracil) separately for 24
h. One milliliter of cells were then aspirated, lysed in 300 µl of
Tris-HCL buffer and resolved on 10% SDS-polyacrylamide gels
followed by transferring of the proteins to PVDF membranes
(Millipore) and blocking with 5% non-fat dry milk in PBS-
T (0.05% Tween 20) for 1 h at room temperature. Primary
antibodies including Bid (sc-11243, 1:1000), caspase-3 (sc-7148,
1:1000), caspase-8 (sc-56070, 1:1000), caspase-9 (sc-56076,
1:1000), anti β-actin (sc-47778, 1:5000), Bax (sc-23959, 1:1000)
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), Bcl-XL
(ab32370, 1:1000), Bcl-2 (ab7973, 1:1000), and p53 (ab2433,
1:1000) (Abcam Inc., Cambridge, MA, USA). Secondary
FIGURE 2 | NTC arrests the cell cycle in the S/M phase. Cells were incubated with DMSO (control negative) and NTC (6.0µM) for 24 h following collection and
staining with BrdU and Phopho-Histone H3. Treatment with NTC revealed no significant changes in the BrdU and Phosho-Histone H3 fluorescence intensity which
suggests that the cells have not been arrested at S/M phase.
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FIGURE 3 | Effect of NTC on development of cell cycle using flow cytometry. Momentous cell cycle arrest was identified at G1 phase after 24 and 48 h
incubation of the cells with NTC. All data were expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.
antibodies conjugated to horseradish peroxidase were obtained
from Kirkegaard & Perry Laboratories, Inc. (Gaithersburg,
MD, USA). Protein-antibody complexes were detected using
Amersham ECL prime Western blotting detection reagent (GE
Healthcare, Munich, Germany).
Statistical Analysis
All values are expressed as mean ± S.D. Student’s t-test was used
for statistical evaluation of data. Probability values ∗p < 0.05
were considered statistically significant.
RESULTS
Structure Elucidation
The synthetic steps for the preparation of ligand (L) is shown
in Figure 1A. The structural formula of L was ascertained from
1H-NMR and FTIR spectroscopies. The 1H-NMR spectrum
supported the proposed structural formula (Figure 1B). The
amide protons appear as a singlet at 7.71 ppm, and all aromatic
protons appear as a multiplet in the range 7.44–7.51 ppm. Ni
(II) complex containing polymeric ligand was synthesized as a
greenish precipitate in ethanolic solution owing to their low
ethanol solubility (Figure 1C). The complex is a dinuclear repeat
unit and stable toward air and moisture. It is soluble in DMSO
but insoluble in common organic solvents. The FTIR spectra
of L and its complex showed a broad band at 3324 cm−1 and
3326 cm−1 that is assigned ν (N-H) amide. FTIR spectra of L
showed the absence of bands of ν(C=O) and ν(NH2), which were
present in the starting material. It is due to the formation of an
amide bond ν(C=O) that indicates the condensation of the two
moieties (a carboxylic acid monomer and an amine monomer).
Its complex showed a weak band at low frequency 569 cm−1,
revealing the coordination between nickel ion and nitrogen
atom of the ligand. The 1COO value (COOasy–COOsym) of its
complex was 130 cm−1, suggesting a chelating binding mode for
carboxylate coordination mode. The UV-visible spectrum of Ni
(II) complex indicates the octahedral geometry at Ni (II) center.
Cytotoxic Effect of NTC on Proliferation of
Cancer Cells
The cytotoxic effect of NTC was evaluated on WiDr and HT-
29 and CCD-18Co by the MTT assay in triplicate. IC50 values
for the compound and standard on cell lines tested in this work
are shown in Table 1. The NTC displayed a very significant
inhibitory effect toward both cancer cells after 24 h. The IC50 of
NTC against WiDr and HT-29 were calculated as 6.07± 0.22µM
and 6.26± 0.13µM, respectively, as compared with the standard
(1.04 ± 0.14) but the IC50 of NTCin normal cells was 55.16 ±
0.07µM.
NTC Induced G1 Cell cycle Arrest
Development of cancer is due to dysfunction in the regulation of
the cell cycle that results in over-proliferation of cells. However,
cancer progression can be strongly limited by conquest of the cell
cycle. Hence, the effect of 6.0µM NTC on cell cycle arrest was
investigated. The BrdU and phospho-histone H3 staining of HT-
29 and WiDr cells treated with NTC showed that cell cycle arrest
at the S/M phases did not occur (Figure 2). However, cellular
arrest in the G1 phase was detected by using flow cytometry
(Figure 3).
NTC Enhanced Cytochrome C Release and
Membrane Permeability but Reduced
Mitochondrial Membrane Potential
Because of the cytotoxic effect of NTC on WiDr and HT-29
cells, the membrane permeability was much higher than the
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FIGURE 4 | Immunofluorescence study of the effect of NTC. (A) After treatment of the cells with NTC (6.0µM), Hoechst 33,342, cytochrome c, membrane
permeability and mitochondrial membrane potential dyes were applied. (B) Representative bar charts indicate a dose-dependent reduction of MMP (JC-1), elevated
cell permeability and cytochrome c release in treated cells. All data were expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared
with the no-treatment group.
control suggesting sustained apoptotic activity in these cells
(Figure 4A). Loss of mitochondrial membrane potential (MMP)
is a conceivable mechanism for cell death evidenced by MMP
dye (JC-1) which stained control cell cytoplasm stronger than
cells treated with NTC. The WiDr and HT-29 cells treated
with NTC for 24 h exhibited a dose-dependent reduction of
MMP fluorescence intensity, as a result of collapsed MMP. The
fluorescence intensity in the cytosol of WiDr and HT-29 cells
treated with NTC was less than control cells suggesting the
release of cytochrome c. In addition, increase in the plasma
membrane permeability was evidenced by increase in the green
fluorescent intensity of NTC-treated cancer cell lines (Liew et al.,
2014) which confirm that NTC disturb the plasma membrane
and increase the permeability as result of its cytotoxic potential
(Figures 4A,B).
Cytoskeletal Rearrangement and Nuclear
Fragmentation
WiDr and HT-29 cells treated with NTC were examined
for cytoskeletal and nuclear morphological alteration by
phalloidin and Hoechst 33,342 staining. Staining of F-
actin at the peripheral membrane showed cell shrinkage
(Supplementary Figure 1). Nuclear condensation and
fragmentation were detected at a concentration of 6.0µM
of NTC in 24 h (Supplementary Figure 2). Additionally,
apoptotic chromatin changes increased nuclear intensity which
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FIGURE 5 | Translocation of NF-κB. After treatment of both cancer cells by several concentration of NTC for duration of 3 h, the cells were exposed for 30min to
TNF- α (1 ng/ml). Results disclosed no significant cytoplasmic to nucleus translocation of NF-κB. All data were expressed as the means ± standard error of triplicate
measurements. *P < 0.05 compared with the no-treatment group.
suggested that NTC induced apoptosis in these cells (Liew et al.,
2014).
Morphological Changes in the
NTC-Induced Apoptosis Cells
After 24 h treatment of WiDr and HT-29 cells with 6.0µM
of NTC, the apoptotic features were analyzed by using a
fluorescence microscope. Normal nuclear structure in control
cells was displayed as green fluorescence, whereas it was bright
green in early apoptotic cells caused by interposition of acridine
orange with the fragmented DNA. After 24 h, nuclear chromatin
pucker and membrane zeiosis were detected as moderate
apoptotic features. After 48 h, the reddish-orange color due to
binding of propidium iodide to denatured DNA identified the
late stage of apoptosis (Supplementary Figure 3).
Evaluation of Reactive Oxygen Species
Production
To evaluate the ROS production in the WiDr and HT-29 cells
treated with NTC for 24 h, DHE dye was used for staining the
live cells after NTC treatment. Following a rapid oxidation of
DHE and producing DCF by ROS, the fluorescent intensity
was identified by Radiance 2100 confocal microscope (Bio-
Rad, Hercules, CA, USA). The DCF fluorescence levels in the
cells were remarkably increased in a dose-dependent manner
(Supplementary Figure 4).
Cytotoxic Potential of NTC on Releasing of
LDH
The potential of cytotoxic effect of NTC on cancer cell
lines was analyzed at different concentrations after 24 h. The
NTC significantly induced release of lactate dehydrogenase.
This enzyme is a biomarker of the loss of membrane
integrity, apoptosis and necrosis. Results revealed occurrence
of cytotoxicity at a concentration of 6.0µM after 24 h
(Supplementary Figure 5).
NTC Mediated NF-κB Translocation
Substantial suppressive effect against translocation of TNF-α-
stimulated NF-κB in WiDr and HT-29 cells was identified
at 6.0µM of NTC (Figure 5). Non-stimulated state was
distinguished by the high NF-κB fluorescence intensity in the
cytoplasm of normal cells. High fluorescence intensity was also
observed in the nucleus of cancer cells. NTC Activates apoptosis
by preventing the activation of NF-κB and its subsequent
translocation to the nucleus.
NTC Upregulated Expression of
Gluthatione Reductase
To identify the expression of the genes involved in cellular
stress response in the WiDr and HT-29 cells treated with NTC,
real time profiler qPCR-array was used. In this method, 84
human genes involved in the oxidative stress and antioxidant
defense, antioxidant peroxiredoxin (PRDX) family and redox
control were examined. Results showed that the oxidative
stress and antioxidant-related genes were differentially expressed
in the cells in response to NTC. Interestingly, glutathione
reductase was significantly up-regulated >80-fold in both
cancer cells as compared with normal cells (P < 0.05).
This finding was confirmed with further independent qPCR
(Supplementary Figure 6).
NTC Induced Caspase-3/7, -8, and, -9
The bioluminescent intensity of caspase-3/7, 8 and 9 activities
of NTC treated cells were measured at 6, 12, 18, 24, 30, 36, and
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FIGURE 6 | Time-dependent activation of caspase 3/7, 8 and 9 by NTC
(6.0µM). The results disclosed a significant activation in caspase 3/7, 8, and 9
in a time-dependent manner. All data were expressed as the means ±
standard error of triplicate measurements.
42 h time points. Significant increases in caspase-3/7, 8, and 9
activities was detected in the colon cancer cells after 18 and 24 h
of NTC exposure (Figure 6). The highest activity for caspase-9
was observed in both cancer cell lines after 18 h of treatment with
NTC (5-folds for both cancer cells). After 24 h of NTC exposure
caspase-3/7 and 8 activities were increased to a peak in both
cancer cell lines and then gradually decreased at the later time
points, suggesting that NTC induces apoptosis in WiDr and HT-
29 through activation of caspase-9 and 8. Vis-a-vis, addition of
caspase inhibitor, Z-VAD-FMK (10µM) inhibited caspase 3/7, 8,
and 9 activities in the presence of 6.0µMNTC.
NTC induced Both Mitochondrial and
Extrinsic Pathways
Western blot analysis revealed a dose-dependent reduction of
Bcl-2 (26 KDa) and Bcl-xL (30 KDa) expression levels in WiDr
and HT-29 cells treated with NTC. In both colon cancer cell
lines, the levels of Bcl-2 and Bcl-xL proteins were substantially
altered at 6.0µM NTC (Figure 7). In addition, upregulation of
p53 (53 KDa) and Bax (23 KDa), cleavage of Bid (22 KDa)
to its truncation (15 kDa) as well as cleavage of caspase-7 (20
KDa), 8(43 KDa), and 9(37 KDa) were evident in both cell
lines. Caspase 3 (17 and 11 kDa subunits) cleavage was detected
in cancer cells treated with NTC, but was not seen in normal
cells with the similar treatment dosages (Figure 7). This finding
suggests that NTC induces apoptosis through bothmitochondrial
and extrinsic pathways. The NTC also modulates binding of
truncated Bid to Bax resulting in the release of cytochrome c from
mitochondria.
Detection of Apoptosis
Cells were pre-treated with cell membrane permeable calcium
chelator EGTA/AM (25µM) for 1 h followed by addition of NTC
(6.0µM) for 24 h. Cells were stained with Annexin V FITC and
PI then subjected to flow cytometry analysis. Our data indicates
that apoptosis induction byNTC occurred even in the presence of
the calcium chelator (Figure 8). This finding suggests that NTC
initiates caspase 8 activation and apoptosis independent from
calcium signaling.
DISCUSSION
Initiation and progression of cancer is mostly coupled to
defective or inefficient apoptosis in normal cells. Therefore,
discovery of target selective therapeutic drugs is associated to
the comprehensive conception of apoptotic signaling pathways.
The cytotoxic properties of nickel(II) complex against colon
cancer cell lines were evaluated throughout the current study.
Particularly, the NTC was able to initiate a simultaneous
activity of mitochondrial and extrinsic pathways of apoptosis
in colon cancer cells. The NTC selectively displayed a potent
suppressive effect against cancer cells with insignificant influence
on normal cells. This phenomenon is affirmed as a significant
feature of nickel complexes in the treatment of cancer. To
sum up, the cytotoxic effect of NTC against colon cancer
cells is associated with both extrinsic and intrinsic apoptotic-
dependent signaling pathways. Morphological and biochemical
alterations are the two significant events of apoptosis. Following
inducing signals in the cell, morphological modifications such
as cell shrinkage, chromatin condensation, membrane blebbing,
and nuclear fragmentation appear which subsequently form
apoptotic bodies. In this study, analysis of the cell membrane
permeability, LDH and cytochrome C release, cytoskeleton
rearrangement, generation of ROS, mitochondrial membrane
potential, nuclear fragmentation and NF-κB translocation was
carried out to investigate the NTC-induced cytological changes
in colon cancer cells. Results showed that NTC can stimulate
cytoskeleton shrinkage-related reorganization. In addition, the
NTC, at a concentration of 6.0µM, substantially damaged
membrane integrity and subsequent releasing of LDH from
the cells (Supplementary Figure 5). Morphological alterations
relevant to the apoptosis was examined through analysis of
membrane blebbing and chromatin condensation by using
AO/PI staining (Supplementary Figure 3; Aarts et al., 2012). By
increasing the period of the cell exposure to NTC from 24 to
72 h, modifications of the early to the late stage of apoptotic
events appeared (Gasparri et al., 2006; Tentner et al., 2012; Wang
et al., 2012). Cell cycle distribution was verified by using BrdU
and phospho-histone H3 staining (Gasparri et al., 2006; Tentner
et al., 2012; Wang et al., 2012). Results showed that neither BrdU
attachment nor H3 staining in the mitotic stage indicates any
remarkable changes of the cell number in S/M phase. Subsequent
flow cytometry examination showed that cell arrest occurred at
the G1 phase. This finding confirms that cell death was triggered
by apoptosis (See et al., 2010; Liu et al., 2012). Mitochondria
controls the fate of the cells via shifting in the level of ROS.
Based on our data, an elevated level of ROS in the NTC-treated
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FIGURE 7 | Western blot analysis of cancer and normal cell lines. Cells were treated with 3.0 and 6.0µM of NTC for 24 h. Proteins were transferred to a
membrane and followed by probing with antibodies. Normalization of band densities of treated samples were accomplished based on the control. The results
represent significant increase in the expression level of caspase 3, 7, 8, 9, p53, Bax and conversion of Bid to its truncated, whereas decrease in Bcl-2 and Bcl-xL level.
cells (6.0µM)was determined. This process is controlled through
upregulation of GR as shown by qRT-PCR. GR is an oxidative
stress indicator and plays a significant role in the scavenging
of reactive oxygen species and anti-oxidant function. Enhanced
ROS production by NTC could stimulate de novo synthesis of GR
(Wu et al., 2004). Disproportionate ROS production diminishes
mitochondrial membrane potential leading to the release of
cytochrome c from mitochondria into the cytoplasm. Increased
mitochondrial cytochrome c levels in the cytoplasm is a key
initiative signal for induction of intrinsic apoptosis pathway at
6.0µM NTC (Bishayee et al., 2013; Zhang et al., 2013). Thus,
NTC can be said to be a potential inducer of morphological
modifications downstream of apoptotic molecular events in the
colon cancer cells associated with its cytotoxic potential.
The apoptosis mechanism is specified by a series of
morphological modifications which are triggered by various
molecular events to undergo cell death rather than its recovery.
Previous studies have demonstrated the cytotoxic effect of
some nickel containing compounds such as nickel complex
of thiosemicarbazones, nickel(II) complexes with furanylmethyl
and thienylmethyl dithiolenes [1,3-dithiole-2-one and 1,3-
dithiole-2-thione], nickel chelates of 5-dimethylaminomethyl-
2-thiouracil (Afrasiabi et al., 2005; Chohan et al., 2006). To
further support the role of NTC in cell death scenarios, we
analyzed the apoptotic pathways in the colon cancer cell lines.
Results showed that NTC enhanced the release of mitochondrial
cytochrome c which activated caspase 9 by 3-folds in colon cancer
cells. Interestingly, activated caspase-8 is also increased by 2-
folds in cancer cells, suggesting that NTC-induced apoptosis is
mediated by more than one pathway. Following cell excitation,
calcium ions are released from mitochondria to regulate several
cellular processes such as apoptosis. Apoptosis can be directed
by calcium signaling. Furthermore, this ion plays an essential
role in the control of cell death, although calcium overload
is associated with the necrosis. Therefore, prolonged elevation
of cytosolic calcium ions causes cell death (Chou et al.,
2010). In addition, mitochondrial calcium ion uptake alters the
mitochondrial permeability which activates apoptosis events in
response to the stress (Gerasimenko et al., 2002). Our data
shows that addition of EGTA/AM, diminishes cytosolic calcium
ion in both early and late stages of apoptosis within the
cancer cell lines (Figure 8). This finding suggests that NTC
initiates apoptosis independent from calcium signaling. Calcium
chelator (EGTA/AM) application and flow cytometry analysis of
Annexin-V in the NTC- treated cells demonstrated the absence of
cytosolic free calcium and increased the number of cells. Hence
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FIGURE 8 | Quality assay of apoptosis. Cells were treated with EGTA/AM (25µM) prior to exposure to NTC 6.0µM. Apoptosis analysis shows (Left to right); the
untreated cells as the control; 24 h NTC-treatment of the cells; 24 h NTC-treatment+ EGTA/AM.
NTC can activate caspase 8 independently from intracellular
calcium ion concentrations.
Resistance of colon cancer to chemotherapy is linked to
the modification of the interconnection of apoptosis and NF-
κB pathways (Park et al., 2015). The process of apoptosis is
regulated by NF-κB signaling pathway (Bkarett and Gilmoer,
1999). The B-cell lymphoma 2 (Bcl-2), Bcl extra-large (Bcl-xl),
p53, caspase-8, and BH3 interacting-domain death agonist (Bid)
are important elements of mitochondria-dependent apoptotic
response to drugs. Both Bcl-2 and Bcl-xl belong to the anti-
apoptotic Bcl-2 family, the trans-membrane proteins in the
mitochondria. Bcl-xl can block cell death through maintenance
of mitochondrial homeostasis and Bcl-2, as a checkpoint assists
the implementation of caspase cascade (Vander Heiden et al.,
1997; Opferman, 2008). Expression of Bcl-2 can be reduced by
P53, an apoptosis mediator. Damage of DNA activates p53 to
trigger apoptosis and eliminate the permanently injured cells
(Ermolaeva and Schumacher, 2014). Defect of Bcl-2, Bcl-xl, and
p53 contributes to tumor development and resistance of the
cells to chemotherapeutic response (Hassan et al., 2014). Some
cytotoxic drugs can also induce caspase-8 to convert Bid to its
translocation form (tBid) leading to the release of mitochondrial
cytochrome c into the cytoplasm and then activating Bax (Gu
et al., 2005; Schug et al., 2011). Results of the current study prove
that NTC potentially reduces the levels of Bcl-2 and Bcl-xl, but
increases p53 concentration in the colon cancer cells. Moreover,
NTC induces the process of cell death through upregulation of
Bax and caspase-8/Bid pathway in the colon cancer cell lines.
In contrast, the NTC did not activate the NF-κB pathway.
This finding supports previously reported data showing that
enhanced activity of NF-κB pathway contributes to resistance to
anticancer drugs (Bishayee et al., 2013; Shakibaei et al., 2013). NF-
κB antagonists could inhibit binding of this molecule to DNA
resulting in suppression of cell proliferation. Together, NTC
exerts cell death potential through inducing apoptotic pathways
and declining the NF-κB pathway.
CONCLUSION
Evaluating the cytotoxic properties of NTC in the current study
suggests that this compound has potential apoptosis induction
ability against colon cancer cells. NTC simultaneously induces
both internal and external apoptosis pathways, and hence, can
be nominated as a potential anti-cancer agent for future in vivo
studies.
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Supplementary Figure 1 | Cytoskeletal rearrangement potential of NTC.
Cells were treated with various concentration of NTC for 24 h with following
fixation and staining with Hoechst 33342 and phalloidin. Dose dependent increase
of phalloidin intensity was observed in both WiDr and HT-29 cells. Bar charts are
showing the average fluorescence intensity of phalloidin. All data were expressed
as the means ± standard error of triplicate measurements. ∗P < 0.05 compared
with the no-treatment group.
Supplementary Figure 2 | Nuclear DNA fragmentation occurs by NTC
treatment. Cells were treated with NTC (6.0µM µ/ml) for 24 h which followed by
fixation and staining using Hoechst 33342. DNA fragmentation is indicated by red
circles.
Supplementary Figure 3 | AO/PI double-staining. Figure reveals that
untreated cells remained healthy after 72 h. Moreover, early apoptotic features
such as chromatin condensation and blebbing were witnessed after 24 and 48 h.
However, after 72 h of NTC treatment (6.0µM), late apoptosis event was
observed. A, Blebbing of cell membrane; B, Late apoptosis; C, Chromatin
condensation; D, Viable cells.
Supplementary Figure 4 | Production of ROS based on the effect of NTC
(6.0µM). Formation of ROS was significantly increased in both cancer cell lines.
All data were expressed as the means ± standard error of triplicate
measurements. ∗P < 0.05 compared with the no-treatment group.
Supplementary Figure 5 | Cytotoxic evaluation of NTC using lactate
dehydrogenase (LDH) assay. Bar charts represent that NTC was significantly
able to elevate the release of LDH at the concentration of (6.0µM). All data were
expressed as the means ± standard error of triplicate measurements. ∗P < 0.05
compared with the no-treatment group.
Supplementary Figure 6 | Results showed that glutathione reductase was
significantly up-regulated >80-fold in both cancer cells as compared with
normal cells (P < 0.05).
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